Home › NDC Lookup › RxCUI directory › RxCUI 996101

Dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule [Jalyn] — RxCUI 996101

RxNorm drug concept · Semantic branded drug
RxCUI 996101 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI996101
Official nameDutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule [Jalyn]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asJalyn (dutasteride 0.5 MG / tamsulosin HCl 0.4 MG) Oral Capsule; Jalyn 0.5 MG / 0.4 MG Oral Capsule
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dutasteride: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It takes time — don't expect overnight results. Most men start noticing improvement in urinary symptoms over several months, and the full benefit on prostate size can take up to 6...
  • How long does it take for dutasteride to actually work?
  • It's a real possibility, and your doctor should know if it becomes a problem. The most common sexual side effects are trouble getting or keeping an erection, lower sex drive, and c...
  • Will this medication affect my sex life?
📖 Read our full Dutasteride guide →

🕸️ Concept Web — How Dutasteride 0.5 MG / tamsulosin hydrochloride 0.... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule [Jalyn] RxCUI 996101

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Dutasteride 228790
    • Tamsulosin 77492
    • Dutasteride / tamsulosin 1001472
    • Tamsulosin hydrochloride 236495
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Jalyn 996098
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dutasteride / tamsulosin Oral Capsule 996096
    • Dutasteride / tamsulosin hydrochloride Oral Capsule 2646819
    • Dutasteride / tamsulosin Oral Product 1160794
    • Dutasteride / tamsulosin Pill 1160795
    • Dutasteride / tamsulosin hydrochloride Oral Product 2662352
    • Dutasteride / tamsulosin hydrochloride Pill 2659810
    • Dutasteride / tamsulosin Oral Capsule [Jalyn] 996100
    • Dutasteride / tamsulosin hydrochloride Oral Capsule [Jalyn] 2658872
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule SCD · 996097
  • Dutasteride 0.5 MG SCDC · 350640
  • Tamsulosin hydrochloride 0.4 MG SCDC · 863668
  • Dutasteride / tamsulosin Oral Capsule SCDF · 996096
  • Dutasteride / tamsulosin hydrochloride Oral Capsule SCDFP · 2646819
  • Dutasteride / tamsulosin Oral Product SCDG · 1160794
  • Dutasteride / tamsulosin Pill SCDG · 1160795
  • Dutasteride / tamsulosin hydrochloride Oral Product SCDGP · 2662352
  • Dutasteride / tamsulosin hydrochloride Pill SCDGP · 2659810

Brand-Name Concepts

  • Dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG [Jalyn] SBDC · 996099
  • Dutasteride / tamsulosin Oral Capsule [Jalyn] SBDF · 996100
  • Dutasteride / tamsulosin hydrochloride Oral Capsule [Jalyn] SBDFP · 2658872
  • Jalyn Oral Product SBDG · 1167806
  • Jalyn Pill SBDG · 1167807
  • Jalyn BN · 996098

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 996101 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80725-0809-13 30 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-13) Jalyn Waylis Therapeutics 2024-03-01
80725-0809-59 90 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-59) Jalyn Waylis Therapeutics 2024-03-01
Observed labelers: Waylis Therapeutics (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.